Nordea Investment Management
CVS icon

Nordea Investment Management’s CVS Health CVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$298M Sell
4,341,044
-70,138
-2% -$4.82M 0.28% 101
2025
Q1
$300M Sell
4,411,182
-800,042
-15% -$54.4M 0.32% 88
2024
Q4
$234M Sell
5,211,224
-1,579,558
-23% -$70.8M 0.24% 111
2024
Q3
$429M Sell
6,790,782
-540,096
-7% -$34.1M 0.49% 49
2024
Q2
$438M Sell
7,330,878
-949,461
-11% -$56.7M 0.51% 43
2024
Q1
$660M Sell
8,280,339
-719,589
-8% -$57.4M 0.78% 24
2023
Q4
$711M Sell
8,999,928
-543,089
-6% -$42.9M 0.9% 22
2023
Q3
$670M Sell
9,543,017
-298,811
-3% -$21M 0.93% 22
2023
Q2
$678M Sell
9,841,828
-610,528
-6% -$42.1M 0.93% 21
2023
Q1
$780M Buy
10,452,356
+1,180,537
+13% +$88.1M 1.14% 15
2022
Q4
$863M Buy
9,271,819
+574,495
+7% +$53.5M 1.34% 11
2022
Q3
$849M Sell
8,697,324
-983,166
-10% -$96M 1.37% 9
2022
Q2
$900M Buy
9,680,490
+2,697,382
+39% +$251M 1.34% 8
2022
Q1
$717M Sell
6,983,108
-1,844,748
-21% -$189M 0.9% 24
2021
Q4
$912M Sell
8,827,856
-91,340
-1% -$9.44M 1.09% 16
2021
Q3
$778M Sell
8,919,196
-266,696
-3% -$23.3M 1.01% 20
2021
Q2
$766M Buy
9,185,892
+6,219
+0.1% +$519K 1.03% 20
2021
Q1
$696M Buy
9,179,673
+55,685
+0.6% +$4.22M 1.01% 22
2020
Q4
$623M Buy
9,123,988
+296,234
+3% +$20.2M 1% 20
2020
Q3
$514M Sell
8,827,754
-9,690,890
-52% -$564M 0.96% 24
2020
Q2
$1.19B Buy
18,518,644
+8,837,591
+91% +$567M 1.23% 18
2020
Q1
$569M Buy
9,681,053
+108,587
+1% +$6.38M 1.37% 16
2019
Q4
$708M Sell
9,572,466
-251,110
-3% -$18.6M 1.41% 14
2019
Q3
$613M Sell
9,823,576
-1,175,093
-11% -$73.4M 1.34% 14
2019
Q2
$600M Sell
10,998,669
-1,428,076
-11% -$77.9M 1.34% 16
2019
Q1
$670M Buy
12,426,745
+340,315
+3% +$18.4M 1.4% 13
2018
Q4
$792M Buy
12,086,430
+1,269,136
+12% +$83.2M 1.88% 6
2018
Q3
$852M Sell
10,817,294
-581,118
-5% -$45.7M 1.76% 8
2018
Q2
$733M Sell
11,398,412
-3,018,529
-21% -$194M 1.76% 8
2018
Q1
$897M Sell
14,416,941
-71,607
-0.5% -$4.45M 2.15% 6
2017
Q4
$1.05B Buy
14,488,548
+383,817
+3% +$27.8M 2.48% 3
2017
Q3
$1.15B Sell
14,104,731
-50,191
-0.4% -$4.08M 2.76% 3
2017
Q2
$1.14B Buy
14,154,922
+1,100,373
+8% +$88.5M 2.87% 3
2017
Q1
$1.02B Sell
13,054,549
-231,722
-2% -$18.2M 2.71% 2
2016
Q4
$1.05B Buy
13,286,271
+682,030
+5% +$53.8M 2.77% 4
2016
Q3
$1.12B Buy
12,604,241
+959,810
+8% +$85.4M 2.91% 4
2016
Q2
$1.11B Buy
11,644,431
+4,423,216
+61% +$423M 3.12% 2
2016
Q1
$749M Buy
7,221,215
+2,017,610
+39% +$209M 2.26% 6
2015
Q4
$509M Buy
5,203,605
+886,903
+21% +$86.7M 1.73% 12
2015
Q3
$416M Buy
4,316,702
+525,086
+14% +$50.7M 1.54% 14
2015
Q2
$398M Buy
3,791,616
+42,202
+1% +$4.43M 1.39% 19
2015
Q1
$387M Buy
3,749,414
+224,157
+6% +$23.1M 1.39% 18
2014
Q4
$340M Buy
3,525,257
+766,288
+28% +$73.8M 1.25% 21
2014
Q3
$220M Buy
2,758,969
+206,831
+8% +$16.5M 0.88% 33
2014
Q2
$192M Sell
2,552,138
-124,165
-5% -$9.36M 0.8% 33
2014
Q1
$200M Buy
2,676,303
+135,932
+5% +$10.2M 0.93% 29
2013
Q4
$182M Buy
2,540,371
+194,352
+8% +$13.9M 0.91% 29
2013
Q3
$133M Buy
2,346,019
+707,448
+43% +$40.1M 0.74% 35
2013
Q2
$93.7M Buy
+1,638,571
New +$93.7M 0.58% 45